Stroke Recognition and Emergency Treatment

Stroke is the fifth leading cause of death in the United States and a primary driver of long-term adult disability, according to the American Stroke Association. The effectiveness of treatment depends directly on the speed of recognition — both by bystanders and by emergency personnel — and on the systematic activation of hospital-based treatment protocols. This page covers the clinical definitions, physiological mechanics, classification frameworks, diagnostic considerations, common misconceptions, and the structured response sequence used in emergency stroke care.

• Definition and scope
• Core mechanics or structure
• Causal relationships or drivers
• Classification boundaries
• Tradeoffs and tensions
• Common misconceptions
• Checklist or steps (non-advisory)
• Reference table or matrix

Definition and scope

A stroke is defined by the American Heart Association (AHA) as a sudden interruption or rupture of blood supply to the brain, producing neurological deficits lasting more than 24 hours or resulting in death. When deficits resolve within 24 hours without evidence of infarction on imaging, the event is classified as a transient ischemic attack (TIA), though this distinction carries significant clinical weight because TIA is associated with an elevated short-term risk of completed stroke.

The scope of stroke as a public health emergency is substantial. The Centers for Disease Control and Prevention (CDC) estimates that approximately 795,000 strokes occur in the United States each year, of which roughly 610,000 are first or new strokes. Stroke accounts for approximately 1 in every 19 deaths in the US (CDC). Emergency medicine intersects with stroke care at the critical juncture where time-sensitive interventions — particularly thrombolysis and mechanical thrombectomy — remain clinically actionable.

The broader regulatory and institutional context for emergency medicine, including CMS certification standards and The Joint Commission's Primary Stroke Center certification program, directly shapes how emergency departments are required to structure stroke response systems.

Core mechanics or structure

Ischemic stroke occurs when a blood vessel supplying the brain is occluded, cutting off oxygen and glucose to neurons. Neurons in the ischemic core — the region of densest flow deprivation — begin to die within minutes. Surrounding this core is the ischemic penumbra, a region of reduced but not absent perfusion where neurons remain electrically silent but structurally viable. The penumbra is the primary target of reperfusion therapy: restoring flow to this zone can salvage functional brain tissue.

The principle driving emergency stroke treatment is captured in the phrase "time is brain." Research quantifying this relationship, cited by NINDS (National Institute of Neurological Disorders and Stroke), established that approximately 1.9 million neurons are lost per minute during large-vessel ischemic stroke. The clinical implication is that every 15-minute reduction in treatment time translates to measurably improved functional outcomes.

Hemorrhagic stroke operates through a different mechanism: rupture of a blood vessel causes direct bleeding into brain parenchyma (intracerebral hemorrhage, ICH) or into the subarachnoid space (subarachnoid hemorrhage, SAH). The expanding hematoma compresses surrounding tissue and raises intracranial pressure. Treatment goals shift from reperfusion to hemorrhage control, reversal of anticoagulation where applicable, and management of intracranial hypertension.

Causal relationships or drivers

Ischemic stroke subdivides causally into cardioembolic, large-artery atherosclerotic, small-vessel (lacunar), cryptogenic, and other determined etiologies under the TOAST classification system (Trial of Org 10172 in Acute Stroke Treatment). Cardioembolic strokes, most commonly associated with atrial fibrillation, account for approximately 20% of all ischemic strokes according to the American Heart Association's Stroke Statistics Update.

The modifiable risk factors most consistently linked to stroke include hypertension, diabetes mellitus, hyperlipidemia, atrial fibrillation, smoking, and obstructive sleep apnea. Hypertension is identified by the CDC as the single most important controllable risk factor.

From an emergency presentation standpoint, the driver of clinical urgency is the narrow therapeutic window. Intravenous alteplase (tPA), the primary pharmacological treatment for ischemic stroke, carries an established eligibility window of up to 4.5 hours from symptom onset under AHA/ASA guidelines (though the FDA-approved label is 3 hours; the 4.5-hour extension is supported by the ECASS III trial and endorsed in AHA guidelines). Mechanical thrombectomy for large-vessel occlusion has demonstrated benefit in select patients up to 24 hours from symptom onset in trials including DAWN and DEFUSE 3, published in the New England Journal of Medicine.

Classification boundaries

Strokes are classified along two primary axes: etiology and anatomical territory.

By etiology:
- Ischemic stroke (~87% of all strokes, per CDC): further divided by TOAST criteria into cardioembolic, large-artery, small-vessel, other determined, and cryptogenic subtypes.
- Intracerebral hemorrhage (ICH): spontaneous bleeding into brain parenchyma, most commonly from hypertensive vasculopathy or amyloid angiopathy.
- Subarachnoid hemorrhage (SAH): bleeding into the subarachnoid space, most often from ruptured intracranial aneurysm.

By anatomical territory:
- Anterior circulation (internal carotid artery system): deficits typically include contralateral motor/sensory loss, aphasia (dominant hemisphere), and neglect (non-dominant hemisphere).
- Posterior circulation (vertebrobasilar system): deficits may include vertigo, diplopia, ataxia, dysarthria, and crossed deficits.

The distinction between ischemic and hemorrhagic stroke cannot be made reliably on clinical grounds alone — non-contrast CT remains the standard first imaging step in emergency settings, as it reliably excludes ICH and is available in virtually all emergency-capable hospitals. This is a foundational point in emergency department triage systems as applied to stroke code activation.

Transient ischemic attack (TIA) occupies a classification boundary that carries high downstream risk. The ABCD² score, a validated tool referencing Age, Blood pressure, Clinical features, Duration, and Diabetes, stratifies 2-day stroke risk following TIA, informing admission versus expedited outpatient workup decisions.

Tradeoffs and tensions

The administration of intravenous tPA in acute ischemic stroke involves a fundamental benefit-risk calculation. The drug carries a 2–7% risk of symptomatic intracranial hemorrhage (sICH), a potentially catastrophic complication (per data from the NINDS tPA Stroke Trial). The benefit — improved functional outcome at 90 days — is proportional to how early treatment is given. This creates a tension between thoroughness of clinical evaluation and speed of treatment initiation.

Contraindication lists for tPA are extensive and include recent surgery, prior ICH, platelet counts below 100,000/μL, and blood pressure above 185/110 mmHg at treatment time (AHA/ASA guidelines). The emergency clinician must balance incomplete histories — common in aphasic or unconscious patients — against the risks of both treating and withholding treatment.

A second major tension exists in stroke systems of care: the "drip and ship" model (administering tPA at a non-thrombectomy-capable hospital and transferring) versus "mothership" routing (direct transport to a comprehensive stroke center). EMS routing decisions, addressed within prehospital emergency care and EMS systems, affect which model is applied and with what impact on thrombectomy eligibility.

Wake-up strokes — where the patient awakens with deficits and symptom onset cannot be established — represent a third tension. Imaging-based selection using MRI perfusion or CT perfusion has expanded eligibility for intervention in these cases, but access to advanced imaging at community hospitals remains uneven across US hospital systems.

Common misconceptions

Misconception: Stroke only affects older adults.
Stroke occurs across all age groups. The CDC reports that approximately 34% of people hospitalized for stroke are younger than 65 years. Pediatric stroke, though uncommon, is a recognized entity addressed in emergency medicine training.

Misconception: If symptoms resolve, no emergency evaluation is needed.
TIA symptoms resolve by definition, but TIA carries a 10–15% risk of stroke within 90 days according to the American Stroke Association, with the highest risk concentrated in the first 48 hours. Emergency evaluation is warranted for all suspected TIAs.

Misconception: FAST captures all stroke presentations.
The FAST acronym (Face drooping, Arm weakness, Speech difficulty, Time to call 9-1-1) was designed for public education but misses posterior circulation strokes, which can present primarily as vertigo, imbalance, diplopia, or sudden severe headache without classic anterior deficits. BE-FAST (Balance, Eyes, Face, Arm, Speech, Time) was subsequently developed to address this gap, as noted by the American Heart Association.

Misconception: Hemorrhagic and ischemic stroke require the same emergency treatment.
tPA is absolutely contraindicated in hemorrhagic stroke. Administering it in ICH would expand the hemorrhage with potentially fatal consequences. CT imaging to exclude hemorrhage is a prerequisite — not an optional step — before thrombolytic treatment is initiated.

Checklist or steps (non-advisory)

The following describes the standardized sequence used in hospital-based stroke code activation, reflecting The Joint Commission's Advanced Certification for Comprehensive Stroke Centers and AHA Target: Stroke initiative benchmarks. This is a descriptive reference, not clinical guidance.

Prehospital phase
1. Dispatcher or EMT applies validated stroke screening tool (Cincinnati Prehospital Stroke Scale or Los Angeles Prehospital Stroke Screen).
2. Stroke alert transmitted to receiving hospital while patient is in transit.
3. Last known well (LKW) time documented precisely.
4. Blood glucose measured to exclude hypoglycemia as stroke mimic.

Emergency department arrival phase
5. Stroke team activation upon or before patient arrival (door-to-team time target: ≤15 minutes per AHA Target: Stroke guidelines).
6. Non-contrast CT of the head obtained (door-to-CT target: ≤25 minutes).
7. CT results reviewed by physician (door-to-CT interpretation target: ≤45 minutes).
8. Point-of-care labs including blood glucose, coagulation studies, and platelet count obtained.
9. NIH Stroke Scale (NIHSS) score assessed and documented.

Treatment decision phase
10. IV tPA eligibility assessed against AHA/ASA inclusion and exclusion criteria.
11. For eligible patients: tPA initiated (door-to-needle target: ≤60 minutes; AHA benchmark is ≤60 minutes in ≥85% of eligible patients).
12. CT angiography (CTA) of head and neck performed to evaluate for large-vessel occlusion (LVO).
13. If LVO identified: neurointerventional team activated for thrombectomy evaluation.
14. Patient transferred to stroke unit or neurocritical care unit with continuous neurological monitoring.

A complete index of emergency medicine resources, including the relationship between stroke care and the broader emergency medicine framework, is available at the Emergency Medicine Authority home.

Reference table or matrix

References

• American Heart Association / American Stroke Association — Stroke Guidelines
• Centers for Disease Control and Prevention — Stroke Data and Statistics
• National Institute of Neurological Disorders and Stroke (NINDS)
• The Joint Commission — Advanced Certification for Comprehensive Stroke Centers
• NINDS tPA Stroke Trial — NEJM 1995
• ECASS III Trial — NEJM 2008
• AHA Target: Stroke Initiative
• TOAST Classification — NIH/NLM
• American Stroke Association — About Stroke

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)